Cost-effectiveness of minimally invasive sacroiliac joint fusion

Sacroiliac joint (SIJ) disorders are common in patients with chronic lower back pain. Minimally invasive surgical options have been shown to be effective for the treatment of chronic SIJ dysfunction. To determine the cost-effectiveness of minimally invasive SIJ fusion. Data from two prospective, mul...

Full description

Saved in:
Bibliographic Details
Published in:ClinicoEconomics and outcomes research 2016-01, Vol.8 (Issue 1), p.1-14
Main Authors: Cher, Daniel J, Frasco, Melissa A, Arnold, Renée Jg, Polly, David W
Format: Article
Language:English
Subjects:
Abbreviations
Arthritis
Back pain
Cost analysis
cost-effectiveness analysis
degenerative sacroiliitis
Joint surgery
minimally invasive surgery
Neurosurgery
Original Research
Physical therapy
Preventive medicine
Quality of life
sacroiliac joint arthrodesis
sacroiliac joint disruptions
sacroiliac joint dysfunction
Sensitivity analysis
spine surgery
Studies
Surgery
Surgical outcomes
Survival analysis
Systematic review
Transplants & implants
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sacroiliac joint (SIJ) disorders are common in patients with chronic lower back pain. Minimally invasive surgical options have been shown to be effective for the treatment of chronic SIJ dysfunction. To determine the cost-effectiveness of minimally invasive SIJ fusion. Data from two prospective, multicenter, clinical trials were used to inform a Markov process cost-utility model to evaluate cumulative 5-year health quality and costs after minimally invasive SIJ fusion using triangular titanium implants or non-surgical treatment. The analysis was performed from a third-party perspective. The model specifically incorporated variation in resource utilization observed in the randomized trial. Multiple one-way and probabilistic sensitivity analyses were performed. SIJ fusion was associated with a gain of approximately 0.74 quality-adjusted life years (QALYs) at a cost of US$13,313 per QALY gained. In multiple one-way sensitivity analyses all scenarios resulted in an incremental cost-effectiveness ratio (ICER)
ISSN:1178-6981
1178-6981
DOI:10.2147/ceor.s94266